Heart condition costs under the microscope in massive hospital study
NCT ID NCT06893731
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study collected information from over 15,000 people hospitalized with cardiomyopathy, a heart muscle disease. Researchers looked at how much these hospital stays cost and what the money was spent on. The goal was to understand the real-world financial impact and help manage costs better.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ARRHYTHMOGENIC CARDIOMYOPATHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Fuwai hospital, Beijing, Beijing 100037
Beijing, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Liver clues: a new way to stage heart amyloidosis?
- Can early enzyme therapy save kidneys in fabry disease?
- Can continued lucerastat access help fabry patients?
- Can a daily pill keep a rare heart disease in check for the long haul?
- Heart scans may unlock hidden risks in minority communities
- Can a single gene infusion rewrite the story of fabry disease?